| Amy Beth Weast, MSW, LCSW | |
|
W247s10395 Center Dr, Mukwonago, WI 53149-9166 | |
| (262) 971-9100 | |
| (262) 662-5688 |
| Full Name | Amy Beth Weast |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | W247s10395 Center Dr, Mukwonago, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912292145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1931-123 (Wisconsin) | Primary |
| Entity Name | County Of Waukesha Department Of Finance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740403146 PECOS PAC ID: 3971405481 Enrollment ID: O20040124000130 |
News Archive
The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the development of products for patients with rare diseases, which affect the lives of nearly 30 million Americans.
More than half of teenagers with the most debilitating forms of depression that do not respond to treatment with selective serotonin reuptake inhibitors (SSRIs) show improvement after switching to a different medication combined with cognitive behavioral therapy, researchers at UT Southwestern Medical Center and their colleagues in a multicenter study have found
A new research tool that mimics the behavior of diseased bone marrow provides a new strategy for understanding the bone marrow disease, Shwachman-Diamond syndrome, and hopefully, developing new treatments.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Challenges in Salivary Diagnostics" will take place to discuss the issues with saliva collection and storage, proteomic analyses, and the growing interest and availability of commercial tests for salivary biomarkers.
New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Beth Weast, MSW, LCSW W344s10517 County Rd E, Mukwonago, WI 53149-9552 Ph: (262) 745-7297 | Amy Beth Weast, MSW, LCSW W247s10395 Center Dr, Mukwonago, WI 53149-9166 Ph: (262) 971-9100 |
News Archive
The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the development of products for patients with rare diseases, which affect the lives of nearly 30 million Americans.
More than half of teenagers with the most debilitating forms of depression that do not respond to treatment with selective serotonin reuptake inhibitors (SSRIs) show improvement after switching to a different medication combined with cognitive behavioral therapy, researchers at UT Southwestern Medical Center and their colleagues in a multicenter study have found
A new research tool that mimics the behavior of diseased bone marrow provides a new strategy for understanding the bone marrow disease, Shwachman-Diamond syndrome, and hopefully, developing new treatments.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Challenges in Salivary Diagnostics" will take place to discuss the issues with saliva collection and storage, proteomic analyses, and the growing interest and availability of commercial tests for salivary biomarkers.
New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.
› Verified 6 days ago
Mr. Fred Henry Malesevich, LCSW, ACSW, DAPA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: S110w30520 Ymca Camp Rd, Mukwonago, WI 53149 Phone: 262-777-1833 | |
Mrs. Sandra Lynn Muetzel, L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: W247s10395 Center Dr, Mukwonago, WI 53149 Phone: 262-662-5900 Fax: 262-662-5688 | |
Jeff Stephani, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: W247s10395 Center Dr, Mukwonago, WI 53149 Phone: 262-662-5900 Fax: 262-662-5688 | |
Mrs. Jessica Lynn Elliott, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: W247s10395 Center Dr, Mukwonago, WI 53149 Phone: 262-662-5900 Fax: 262-662-5688 |